MedPath

The effect of hydroalcoholic extracts of Nasturtium officinale on antioxidant markers in chronic hemodialysis patients

Phase 3
Conditions
Patients with end stage kidney disease under hemodialysis.
End stage renal disease
N18.6
Registration Number
IRCT20150622022869N7
Lead Sponsor
Yasouj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
54
Inclusion Criteria

Aged over 18 years;
Receive hemodialysis at least twice a week, for about 3 months;
Negative history of using medications with known effect on inflammatory markers such as corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs) in the last month;
No active infectious diseases, malignant, rheumatic diseases and other inflammatory diseases.

Exclusion Criteria

Patients who require additional supplementary therapies (taking medications that affect the inflammatory process during the study)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bun, cholesterol, Low Density Lipoproteinn, High Density lipoProtein, triglyceride, potassium, albumin, calcium and phosphorus and antioxidant tests including malondialdehyde, glutathione peroxidase, superoxide dismutase, high sensitive-CRP, Total Oxidant capacity, Total Antioxidant capacity, P-SH. Timepoint: At the beginning of the study and 28 days later. Method of measurement: Antioxidant and biochemical tests.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath